Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(11%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_1
1
11%
Ph not_applicable
1
11%
Ph phase_3
1
11%
Ph phase_2
2
22%
Ph phase_4
4
44%

Phase Distribution

1

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
4(44.4%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(7)
Other(1)

Detailed Status

Completed7
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 22 (22.2%)
Phase 31 (11.1%)
Phase 44 (44.4%)
N/A1 (11.1%)

Trials by Status

completed778%
unknown111%
active_not_recruiting111%

Recent Activity

1 active trials
Showing 5 of 9
active_not_recruitingnot_applicable

The Effect of Glucomannan Powder on Improving Gut Microbiota.

NCT07231003
completedphase_4

Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood

NCT01495806
completedphase_4

Effect of Glucomannan Supplementation on Body Weight in Overweight and Obese Children

NCT02280772
completedphase_4

The Effect of Glucomannan Soluble Fiber on Glucose Homeostasis in Patients With Roux En Y (RNY) Gastric Bypass Surgery

NCT02336438
completedphase_3

Glucomannan for Childhood Functional Constipation.

NCT01151878
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07231003Not Applicable

The Effect of Glucomannan Powder on Improving Gut Microbiota.

Active Not Recruiting
NCT01495806Phase 4

Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood

Completed
NCT02280772Phase 4

Effect of Glucomannan Supplementation on Body Weight in Overweight and Obese Children

Completed
NCT02336438Phase 4

The Effect of Glucomannan Soluble Fiber on Glucose Homeostasis in Patients With Roux En Y (RNY) Gastric Bypass Surgery

Completed
NCT01151878Phase 3

Glucomannan for Childhood Functional Constipation.

Completed
NCT01553500Phase 2

Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease

Completed
NCT01709955Phase 1

The Effects of Glucomannan on Weight Loss

Completed
NCT01485718Phase 4

Effect of Daily Glucomannan in Overweight Patients

Unknown
NCT00613600Phase 2

Safety and Effectiveness Study of a Fiber Supplement for Weight Loss

Completed

All 9 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
9